Skip to content

SCHEDULE 13GAccepted Feb 11, 4:08 PM ET

Eikon Therapeutics, Inc. SCHEDULE 13G

Foresite Capital Fund IV, L.P.

Accepted (ET)

4:08 PM

Feb 11, 2026

Filed

Feb 11, 2026

Documents

1

Size

28.6 KB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.